CIRM's 
Governing Board recently approved $15 million for four projects in 
translational awards program, which promises to offer support to invent 
novel stem cells transplants that can be applied to patients during 
clinical trials. Wondering what "translational" might mean in studies, 
involving stem cells? "Translational" implies to researches that take 
the basic results of a clinical study and then advance them in a way 
that they become ready to be tested in patients in various clinical 
trials.
The fund for translating stem cell studies into effective therapies is divided into four researches. They are:
· Alzheimer's disease
· Sickle cell anemia
· Cartilage damage
· Osteonecrosis
Treating Alzheimer's disease:
 Gladstone Institutes in San Francisco received $5.9 million from the 
fund to find out a way to treat Alzheimer's disease. Alzheimer's disease
 has no long-term treatment or no known cure and it affects five million
 Americans.
In the process, the researchers are looking at 
generating brain cells by applying pluripotent stem cells in an induced 
form. Pluripotent stem cells or iPSCs are the adult cells that can be 
reprogrammed to give them the ability to modify into any other cell 
type.
Treating patients with sickle cell anemia:
 The second project involves patients suffering from sickle cell anemia.
 A fund of $4.5 million is approved to the researchers at Children's 
Hospital Oakland Research Institute (CHORI) for the trial.
Sickle 
cell anemia is a genetic blood disorder. It involves severe pain and can
 even lead to organ damage and stroke. The disease has affected over 
100,000 people in the US. Currently, the most effective and long-term 
treatment for this disease involves bone marrow transplant. However, the
 procedure requires a suitably matched donor, which may take months. 
Even though a donor is found, the surgery may still leave a life risk.
Researchers
 found out that the patient's own blood stem cells can eliminate the 
complications and at the same time address the condition. To implement 
the technique, a new gene-editing tool called CRISPR-Cas9 is used by the
 CHORI team. This technique helps to develop a way to edit the defective
 gene causing sickle cell and transform it into a healthy blood supply 
for the affected people.
Treating medically untreated cartilage damage:
 The third portion of the fund went to the University of Southern 
California (USC). The researchers of USC have been granted with $2.5 
million, so that they can develop a full-proof technique to treat 
cartilage damage with stem cell transplant.
Cartilage damage might
 not be life-threatening, but it affects the lifestyle of millions of 
people to a great extent. And if remain untreated for a long time, it 
might result in severe conditions such as chronic pain, degeneration of 
joints and even arthritis.
Treating Osteonecrosis:
 The fourth part of the fund, $2.09 million, went to Ankasa Regenerative
 Therapeutics for a project, involving osteonecrosis. Regenerative 
Therapeutics researchers hope to discover a solution to the painful 
disease, which is caused due to inadequate blood flow to the bones. And 
as the result, the bones begin to rot and then die.
We hope that translational awards programs with stem cell ideas result into effective therapies. Stay tuned for more updates!
http://czwlwz.chaozhou.gov.cn/JForum/user/profile/204549.page
http://bus.gov.ru/forum/user/profile/60654.page
http://zakupki.gov.ru/forum/user/profile/1544338.page
https://torgi.gov.ru/forum/user/profile/456142.page
https://forums.huduser.gov/member.php?action=profile&uid=52730
http://www.social.saratov.gov.ru/services/forum/index.php?PAGE_NAME=profile_view&UID=44743
http://nc.gov.ua/communication/forum/?PAGE_NAME=profile_view&UID=28716
http://minzdrav.saratov.gov.ru/forum/index.php?PAGE_NAME=profile_view&UID=45410
http://wwdcforum.wyo.gov/forum/viewprofile.aspx?UserID=65719
http://tracnghiem.thanhdoan.cantho.gov.vn/blog/index.php?userid=14002
http://monrda.gov.ua/index.php/forum/dobro-pozhalovat/86059-cr-ditos-r-pidos#57698
http://chalmers.in.gov/discuss/?vasthtmlaction=profile&id=12305
http://drohobych-rda.gov.ua/user/ahsenapi/
http://tyachiv-rda.gov.ua/user/ahsenapi/
http://ifinmon.saratov.gov.ru/index.php/forum/user/908-ahsenapi
http://www.kzncomsafety.gov.za/UserProfile/tabid/255/userId/70547/Default.aspx
http://www.unionspringsal.gov/UserProfile/tabid/61/userId/77755/Default.aspx
http://www.kzndsr.gov.za/UserProfile/tabid/356/UserID/1588/Default.aspx
http://thuvienso.khcnbackan.gov.vn/UserProfile/tabid/61/userId/56790/language/en-US/Default.aspx
https://www.rul.asg.pr.gov/UserProfile/tabid/57/UserID/28211/language/en-US/Default.aspx
No comments:
Post a Comment